Lpath, Inc. Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
5/23/2013 9:40:05 AM
More...
|
Lpath, Inc. Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP
3/22/2013 9:00:37 AM
More...
|
Lpath, Inc. to Present at ROTH Capital Partners 25th Annual Growth Stock Conference on March 19, 2013
3/12/2013 9:13:49 AM
More...
|
Lpath, Inc. Signs Collaboration and License Agreement With Provista Diagnostics (PDx) to Develop Cancer Diagnostics
3/6/2013 9:20:35 AM
More...
|
Lpath, Inc. to Present Data at Arrowhead Conferences's 3rd Annual Traumatic Brain Injury Conference on March 7, 2013
2/25/2013 10:21:29 AM
More...
|
Lpath, Inc. Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
2/13/2013 9:52:06 AM
More...
|
Lpath, Inc. Sets Investor Update Conference Call for Thursday, January 3, 2013 at 4:30 p.m. ET
12/27/2012 9:55:05 AM
More...
|
Lpath, Inc. Announces Proposed Public Offering of Common Stock
12/14/2012 9:54:51 AM
More...
|
Lpath, Inc. Granted Key European Patent Related to iSONEP Drug Program
12/5/2012 9:22:49 AM
More...
|
Lpath, Inc. Ranks Eighth Fastest Growing Biotechnology Company and 60th Overall Among N. America's Fastest Growing Companies in Deloitte's 2012 Technology Fast 500
12/3/2012 11:53:46 AM
More...
|
|